A 10-minute point-of-care assay for detection of blood protein adducts resulting from low level exposure to organophosphate nerve agents
- 1 March 2013
- journal article
- research article
- Published by Elsevier BV in Chemico-Biological Interactions
- Vol. 203 (1), 108-112
- https://doi.org/10.1016/j.cbi.2012.11.011
Abstract
No abstract availableKeywords
This publication has 11 references indexed in Scilit:
- Biomarkers of organophosphorus nerve agent exposure: comparison of phosphylated butyrylcholinesterase and phosphylated albumin after oxime therapyArchives of Toxicology, 2009
- Phosphylated tyrosine in albumin as a biomarker of exposure to organophosphorus nerve agentsArchives of Toxicology, 2007
- Role of immunogen design in induction of soman-specific monoclonal antibodiesImmunology Letters, 2005
- Kinetic analysis of interactions between human acetylcholinesterase, structurally different organophosphorus compounds and oximesBiochemical Pharmacology, 2004
- Improvements of the Fluoride Reactivation Method for the Verification of Nerve Agent ExposureJournal of Analytical Toxicology, 2004
- Phosphospecific proteolysis for mapping sites of protein phosphorylationNature Biotechnology, 2003
- Retrospective Detection of Exposure to Organophosphorus Anti-Cholinesterases: Mass Spectrometric Analysis of Phosphylated Human ButyrylcholinesteraseChemical Research in Toxicology, 2002
- Enrichment analysis of phosphorylated proteins as a tool for probing the phosphoproteomeNature Biotechnology, 2001
- Blood Cholinesterases as Human Biomarkers of Organophosphorus Pesticide ExposureReviews of Environmental Contamination and Toxicology, 2000
- A new and rapid colorimetric determination of acetylcholinesterase activityBiochemical Pharmacology, 1961